Frank McCormick Net Worth & Insider Trades
Frank McCormick - Director, Bridgebio Pharma, Inc
What is Frank McCormick's Net Worth?
The current estimated net worth of Bridgebio Pharma, Inc's Director, Frank McCormick, is estimated to be about $27.33M . Frank McCormick owns about 1,200,468 units of Bridgebio Pharma, Inc common stock. In the last 4 years at Bridgebio Pharma, Inc, Frank McCormick has sold an estimated value of $8.03M worth.
What is Frank McCormick's Past Insider Trading?
Frank McCormick's largest sale order was 100,000 units , worth over $4.28M on November 17, 2020. In total, Frank McCormick has made about 5 transactions over 4 years of their time at Bridgebio Pharma, Inc. Frank McCormick usually trades in May, December, July, February and November, with the busiest year in 2020 and 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FRANK MCCORMICK
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Frank McCormick's' Mailing Address?
- Mailing address is C/o Exelixis Inc 170 Harbor Way S San Francisco CA 94083-0511 CA
Bridgebio Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Neil Kumar, Ph.D. | 2020 | $550,000 | $825,000 | $2,368,511 | $6,299,998 | $11,400 | $10,054,909 |
| Neil Kumar, Ph.D. | 2019 | $502,765 | $360,000 | $13,863,445 | $11,573,049 | $34,804 | $26,334,063 |
| Neil Kumar, Ph.D. | 2018 | $450,000 | - | - | - | - | $450,000 |
| Brian Stephenson, Ph.D., CFA | 2020 | $550,000 | $712,500 | $789,494 | $2,099,996 | $11,943 | $4,163,933 |
| Brian Stephenson, Ph.D., CFA | 2019 | $420,000 | $189,000 | $132,600 | $3,430,781 | $26,586 | $4,198,967 |
| Brian Stephenson, Ph.D., CFA | 2018 | $74,375 | $330,240 | $1,942,500 | - | - | $2,347,115 |
| Michael Henderson, M.D. | 2020 | $515,000 | $300,000 | $7,072,500 | $91,899 | $11,843 | $7,991,241 |
| Cameron Turtle, Ph.D.* | 2020 | $400,000 | $210,000 | $3,940,081 | - | $11,400 | $4,561,482 |
| Charles Homcy, M.D. | 2020 | $500,000 | $100,000 | - | $1,199,992 | $55,812 | $1,855,805 |
| Charles Homcy, M.D. | 2019 | $513,808 | - | $2,111,579 | $3,128,716 | $221,737 | $5,975,842 |
| Brian Stolz | 2020 | $511,362 | $25,000 | $736,854 | $1,992,182 | $1,975,453 | $5,240,851 |
| Brian Stolz | 2019 | $146,780 | $93,750 | $6,860,780 | $1,045,003 | - | $8,146,313 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm
What are Bridgebio Pharma, Inc's Past Insider Trades?
Bridgebio Pharma, Inc's most recent insider trade came on September 7, 2023 by Randal Scott who sold 2,500 units worth $75K . In the last 4 years, insiders at Bridgebio Pharma, Inc have sold an estimated value of $424.11M and bought an estimated value of $213.34M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Neil Kumar, CEO and President, Brian C Stephenson, Secretary, and Thomas Michael Henderson, Chief Business Officer .
BridgeBio Pharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||